103 related articles for article (PubMed ID: 20207214)
1. Genetic polymorphism of epidermal growth factor 61A>G and cancer risk: a meta-analysis.
Zhang YM; Cao C; Liang K
Cancer Epidemiol; 2010 Apr; 34(2):150-6. PubMed ID: 20207214
[TBL] [Abstract][Full Text] [Related]
2. Genetic susceptibility of epidermal growth factor +61A>G and transforming growth factor beta1 -509C>T gene polymorphisms with gallbladder cancer.
Vishnoi M; Pandey SN; Modi DR; Kumar A; Mittal B
Hum Immunol; 2008 Jun; 69(6):360-7. PubMed ID: 18571008
[TBL] [Abstract][Full Text] [Related]
3. +61A>G polymorphism in the EGF gene does not increase the risk of lung cancer.
Kang HG; Choi JE; Lee WK; Kam S; Cha SI; Kim CH; Jung TH; Park JY
Respirology; 2007 Nov; 12(6):902-5. PubMed ID: 17986122
[TBL] [Abstract][Full Text] [Related]
4. Meta-analysis of epidermal growth factor polymorphisms and cancer risk: involving 9,779 cases and 15,932 controls.
Li TF; Ren KW; Liu PF
DNA Cell Biol; 2012 Apr; 31(4):568-74. PubMed ID: 22070650
[TBL] [Abstract][Full Text] [Related]
5. Quantitative assessment of the association between +61A>G polymorphism of epidermal growth factor gene and susceptibility to glioma.
Tao Y; Liang G
Tumour Biol; 2014 Jan; 35(1):369-77. PubMed ID: 23963773
[TBL] [Abstract][Full Text] [Related]
6. Association between functional EGF+61 polymorphism and glioma risk.
Costa BM; Ferreira P; Costa S; Canedo P; Oliveira P; Silva A; Pardal F; Suriano G; Machado JC; Lopes JM; Reis RM
Clin Cancer Res; 2007 May; 13(9):2621-6. PubMed ID: 17473192
[TBL] [Abstract][Full Text] [Related]
7. EGF +61A>G polymorphism and gastrointestinal cancer risk: a HuGE review and meta-analysis.
Piao Y; Liu Z; Ding Z; Xu L; Guo F; Sun Q; Xie X
Gene; 2013 Apr; 519(1):26-33. PubMed ID: 23403233
[TBL] [Abstract][Full Text] [Related]
8. The 61 A/G EGF polymorphism is functional but is neither a prognostic marker nor a risk factor for glioblastoma.
Vauleon E; Auger N; Benouaich-Amiel A; Laigle-Donadey F; Kaloshi G; Lejeune J; Delattre JY; Thillet J; Sanson M
Cancer Genet Cytogenet; 2007 Jan; 172(1):33-7. PubMed ID: 17175377
[TBL] [Abstract][Full Text] [Related]
9. Epidermal growth factor genetic variation, breast cancer risk, and waiting time to onset of disease.
Araújo AP; Ribeiro R; Pinto D; Pereira D; Sousa B; Mauricio J; Lopes C; Medeiros R
DNA Cell Biol; 2009 May; 28(5):265-9. PubMed ID: 19388850
[TBL] [Abstract][Full Text] [Related]
10. The DNA repair gene APE1 T1349G polymorphism and cancer risk: a meta-analysis of 27 case-control studies.
Gu D; Wang M; Wang M; Zhang Z; Chen J
Mutagenesis; 2009 Nov; 24(6):507-12. PubMed ID: 19762350
[TBL] [Abstract][Full Text] [Related]
11. Ovarian cancer and genetic susceptibility: association of A61G polymorphism in the EGF gene.
Araújo AP; Ribeiro R; Pereira D; Pinto D; Sousa B; Catarino R; Medeiros R
Exp Biol Med (Maywood); 2009 Mar; 234(3):241-5. PubMed ID: 19144868
[TBL] [Abstract][Full Text] [Related]
12. No association between EGF gene polymorphism and gastric cancer.
Goto Y; Ando T; Goto H; Hamajima N
Cancer Epidemiol Biomarkers Prev; 2005 Oct; 14(10):2454-6. PubMed ID: 16214932
[TBL] [Abstract][Full Text] [Related]
13. FAS promoter polymorphisms and cancer risk: a meta-analysis based on 34 case-control studies.
Zhang Z; Xue H; Gong W; Wang M; Yuan L; Han S; Zhang Z
Carcinogenesis; 2009 Mar; 30(3):487-93. PubMed ID: 19168581
[TBL] [Abstract][Full Text] [Related]
14. Lack of association between EGF +61A>G polymorphism and melanoma susceptibility in Caucasians: a HuGE review and meta-analysis.
Wu D; Wu Y; Zhang X; Cong P; Lv X
Gene; 2013 Feb; 515(2):359-66. PubMed ID: 23201894
[TBL] [Abstract][Full Text] [Related]
15. Epidermal growth factor gene polymorphism is different between schizophrenia and lung cancer patients in Korean population.
Lim YJ; Kim JW; Song JY; Hong MS; Jin SY; Yoon SH; Park HJ; Choe BK; Lee JJ; Yim SV; Hong SI; Baik HH; Ha E; Park YH
Neurosci Lett; 2005 Feb; 374(3):157-60. PubMed ID: 15663953
[TBL] [Abstract][Full Text] [Related]
16. The MPO -463G>A polymorphism and cancer risk: a meta-analysis based on 43 case-control studies.
Chu H; Wang M; Wang M; Gu D; Wu D; Zhang Z; Tang J; Zhang Z
Mutagenesis; 2010 Jul; 25(4):389-95. PubMed ID: 20418356
[TBL] [Abstract][Full Text] [Related]
17. No association between epidermal growth factor and epidermal growth factor receptor polymorphisms and nasopharyngeal carcinoma.
Gao LB; Wei YS; Zhou B; Wang YY; Liang WB; Li C; Li Y; Bai P; Fang WL; Xue H; Zhang L
Cancer Genet Cytogenet; 2008 Sep; 185(2):69-73. PubMed ID: 18722874
[TBL] [Abstract][Full Text] [Related]
18. Genetic polymorphism in EGF is associated with prostate cancer aggressiveness and progression-free interval in androgen blockade-treated patients.
Teixeira AL; Ribeiro R; Cardoso D; Pinto D; Lobo F; Fraga A; Pina F; Calais-da-Silva F; Medeiros R
Clin Cancer Res; 2008 Jun; 14(11):3367-71. PubMed ID: 18519765
[TBL] [Abstract][Full Text] [Related]
19. TGFB1 T29C polymorphism and breast cancer risk: a meta-analysis based on 10,417 cases and 11,455 controls.
Gu D; Zhuang L; Huang H; Cao P; Wang D; Tang J; Chen J
Breast Cancer Res Treat; 2010 Oct; 123(3):857-61. PubMed ID: 20157775
[TBL] [Abstract][Full Text] [Related]
20. The A61G EGF polymorphism is associated with development of extraaxial nervous system tumors but not with overall survival.
Almeida LO; Custódio AC; Santos MJ; Almeida JR; Clara CA; Pinto GR; Rey JA; Casartelli C
Cancer Genet Cytogenet; 2010 Apr; 198(1):15-21. PubMed ID: 20303009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
